Skip directly to content

February 16, 2018 –  On Monday, February 12th, New York State Medicaid Director Jason Helgerson made news by announcing a potential path forward in the State’s response to its major hepatitis C epidemic at the joint Senate/Assembly budget hearing on Health and Medicaid. “We already have statutory authority to look at volume based discounts [for hepatitis C treatment],” Helgerson said in response to a question about improving New Yorkers’ access to hepatitis C treatment from ranking Senate Health Committee Member Senator Gustavo Rivera. “One of the things we’re going to do is—once the prices

February 13, 2018 – Treatment Action Group (TAG) vehemently opposes cuts in the Trump administration’s fiscal year (FY) 2019 budget proposal, which severely threaten the accelerated progress of recent years towards ending the domestic and global HIV/AIDS, tuberculosis (TB) and hepatitis C virus (HCV) epidemics. The latest budget proposal, released yesterday, continues a pattern by the current administration to undermine critical programming and health care necessary to public health globally and in the United States.

“With this latest budget, the Trump administration did exactly what we knew

Pregnant women have frequently been excluded from or de-prioritized in clinical research initiatives due to a multitude of factors, such as the complex physiology of pregnant women, the risk studies may pose to the fetus, and the classification of pregnant women as a vulnerable population, among others. This neglect has left pregnant women and their providers to make decisions without adequate information or guidance regarding the safety and efficacy of necessary treatments.

This was a two part webinar series; Part I was held on Wednesday, February 14th, and was intended to broaden and build

On May 30, 2018, President Trump signed “Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, or S.204,” into law, after the House followed the Senate in caving to libertarian de-regulation pressure. The new law creates a second pathway for pre-approval access, redundant given the Food and Drug Administration (FDA)’s existing and effective Expanded Access Program. Under this new pathway, pharmaceutical manufacturers can provide experimental medicines outside of research without no FDA or investigational review board approval.

Updated Training Manual for Treatment Advocates: Hepatitis C Virus & Coinfection with HIV

View and download the PDFs of the slidedecks that accompany this training manual.

February 1, 2018 – Treatment Action Group has just released an updated Training Manual for Treatment Activists: Hepatitis C and HIV Coinfection.

The purpose of this Training Manual is to provide information for you and your community. This information can be used to advocate for access to prevention and diagnosis of, and care and treatment for, hepatitis C virus (HCV).

The manual is written by and for people who are not medical specialists. We're

February 28, 2018 – This guide is for people who have tuberculosis (TB), people who are at risk for it, and the people who take care of them. It explains what global standards are for TB prevention, treatment, and care, so you can know what services you have the right to receive.

We’ve divided the guide into four sections that cover your human rights and TB; your rights and TB prevention; your rights when it comes to TB diagnosis; and finally your rights and getting TB treatment. 

Below you’ll find download links for the full

TAG Limited Art Editions 1999 — 2017
March 21 — Saturday March 24, 2018
Opening Reception: Wednesday, March 21, 6 - 8 pm
Westbeth Gallery, 55 Bethune St. NYC

Gallery hours: Wednesday thru Saturday from 1 to 8 pm
 

b_thornberry_198x130.jpg               198x130_e_baum_peer_B&W.jpg
Images L to R: Ben Thornberry, ACT UP Demonstration, 1988; Erica Baum, Peer, 2017

Treatment Action Group is pleased to present the historic art exhibition and sale: TAG Limited Art Editions 1999 — 2017, running from Wednesday March 21 through Saturday March 24, 2018 at Westbeth Gallery in New York City. Running from Wednesday March 21 through Saturday March 24, 2018 at

January 24, 2018

José Narro Robles, Mexican Secretary of Health
Ildefonso Guajardo Villarreal, Mexican Secretary of Economy 
Ginette Pepitas Taylor, Canadian Minister of Health
François-Philippe Champagne, Canadian Minister of International Trade
Robert Lighthizer, U.S. Trade Representative
Eric D. Hargan, U.S. Acting Secretary and Deputy Secretary of Health and Human Services

Dear Ministers:

As organizations concerned with health issues domestically and globally, we urge you to ensure that any renegotiation of the North American Free Trade Agreement (NAFTA) does not undermine access to

Partnership between health department leadership and community advocates is integral to the success of EtE initiatives. The advent of TasP and PrEP was a significant part of the first call to end HIV as an epidemic in New York. However, it was a renewed spirit of cooperation between the New York City Department of Health and Mental Hygiene, the New York State Department of Health, and community advocates that provided the opportunity to turn hopeful science into an implementable reality.

Aligning the priorities of state and city health departments with the priorities of the communities they

In 2014, Governor Cuomo announced a three-point plan to end HIV/AIDS as an epidemic in the state. In 2015, a task force appointed by the Governor developed – with extensive input from a parallel ad hoc community “kitchen cabinet” coalition – the New York State Blueprint which includes 30 key recommendations. Several metrics are being tracked in order to assess progress on recommendations from the plan, many of which can be tracked via the online EtE Dashboard.

The New York State AIDS Institute uses nine population-level metrics to help track progress toward Ending the Epidemic by 2020.

Pages